Aclaris Therapeutics has developed a treatment for COVID-19 patients. The investigational drug was developed internally utilizing KINect&reg;, Aclaris Therapeutics' drug discovery platform.

Aclaris Therapeutics

St. Louis

Aclaris Therapeutics startup from St. Louis, United States is ranked 1364 out of 2449 worldwide and 496 from the 748 startups in United States. See more information and additional rankings on the StartupBlink Global Ecosystem Map